Seeing Is Believing
Currently out of the existing stock ratings of Aisyah Noor, 3 are a HOLD (50%), 3 are a BUY (50%).
Analyst Aisyah Noor, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 50% that have a potential upside of 7.45% achieved within 89 days. Previously, Aisyah Noor worked at STIFEL.
Aisyah Noor’s has documented 9 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on QGEN, Qiagen NV at 05-Aug-2024.
Analyst best performing recommendations are on AMFPF (AMPLIFON S.P.A).
The best stock recommendation documented was for AMFPF (AMPLIFON S.P.A) at 12/1/2020. The price target of $41.2 was fulfilled within 177 days with a profit of $5.34 (14.89%) receiving and performance score of 0.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 31-Mar-2022
$35.35
$24.14 (215.34%)
$37.45
3 years 8 months 23 days ago
(09-Feb-2023)
1/2 (50%)
$17.41 (97.05%)
19
Buy Since 13-Sep-2022
$34.25
$23.04 (205.53%)
$31.26
3 years 11 months 10 days ago
(22-Nov-2022)
1/2 (50%)
$10.49 (44.15%)
210
Hold Since 27-Oct-2022
$27.76
$16.55 (147.64%)
4 years 5 days ago
(27-Oct-2022)
1/1 (100%)
$4 (16.84%)
104
Hold Since 09-Dec-2020
4 years 11 months 30 days ago
(02-Nov-2021)
1/1 (100%)
$5.34 (14.89%)
177
What Year was the first public recommendation made by Aisyah Noor?